Evidence map›Paper›PMID 24454836›Full record

ArticlePloS one2014

PprA contributes to Deinococcus radiodurans resistance to nalidixic acid, genome maintenance after DNA damage and interacts with deinococcal topoisomerases.

Swathi Kota, Vijaya K Charaka, Simon Ringgaard, Matthew K Waldor, Hari S Misra

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. PprA Protein Inhibits DNA Strand Exchange and ATP Hydrolysis ofFrontiers in cell and developmental biology · 2021
    Article
  7. PprI: The Key Protein in Response to DNA Damage inFrontiers in cell and developmental biology · 2020
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. PprM, a Cold Shock Domain-Containing Protein fromFrontiers in microbiology · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Swathi KotaMolecular Biology Division, Bhabha Atomic Research Centre, Mumbai, India.
Vijaya K CharakaMolecular Biology Division, Bhabha Atomic Research Centre, Mumbai, India ; Division of Infectious Disease, Brigham and Women's Hospital, Department of Microbiology and Immunobiology, Harvard Medical School, and HHMI, Boston, Massachusetts, United States of America.
Simon RinggaardDivision of Infectious Disease, Brigham and Women's Hospital, Department of Microbiology and Immunobiology, Harvard Medical School, and HHMI, Boston, Massachusetts, United States of America.
Matthew K WaldorDivision of Infectious Disease, Brigham and Women's Hospital, Department of Microbiology and Immunobiology, Harvard Medical School, and HHMI, Boston, Massachusetts, United States of America.
Hari S MisraMolecular Biology Division, Bhabha Atomic Research Centre, Mumbai, India ; Division of Infectious Disease, Brigham and Women's Hospital, Department of Microbiology and Immunobiology, Harvard Medical School, and HHMI, Boston, Massachusetts, United States of America.
Brigham and Women's Hospital · USBhabha Atomic Research Centre · IN

Funding

Molecular Biology and Virulence of CTX PhageR37AI042347 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WALDOR, MATTHEW K · 2008 to 2017
$3.8M
Howard Hughes Medical InstituteNIAID NIH HHS R37 AI042347
6 · The paper itself

Abstract

PprA is known to contribute to Deinococcus radiodurans' remarkable capacity to survive a variety of genotoxic assaults. The molecular bases for PprA's role(s) in the maintenance of the damaged D. radiodurans genome are incompletely understood, but PprA is thought to promote D. radiodurans's capacity for DSB repair. PprA is found in a multiprotein DNA processing complex along with an ATP type DNA ligase, and the D. radiodurans toposiomerase IB (DraTopoIB) as well as other proteins. Here, we show that PprA is a key contributor to D. radiodurans resistance to nalidixic acid (Nal), an inhibitor of topoisomerase II. Growth of wild type D. radiodurans and a pprA mutant were similar in the absence of exogenous genotoxic insults; however, the pprA mutant exhibited marked growth delay and a higher frequency of anucleate cells following treatment with DNA-damaging agents. We show that PprA interacts with both DraTopoIB and the Gyrase A subunit (DraGyrA) in vivo and that purified PprA enhances DraTopoIB catalysed relaxation of supercoiled DNA. Thus, besides promoting DNA repair, our findings suggest that PprA also contributes to preserving the integrity of the D. radiodurans genome following DNA damage by interacting with DNA topoisomerases and by facilitating the actions of DraTopoIB.

Indexed as

DNA DamageGenome, BacterialAnti-Bacterial AgentsBacterial ProteinsBase SequenceDeinococcusDNA PrimersDNA Topoisomerases, Type IDrug Resistance, BacterialNalidixic AcidReverse Transcriptase Polymerase Chain ReactionAnti-Bacterial AgentsBacterial ProteinsDNA PrimersDNA Topoisomerases, Type INalidixic Acid

Identifiers

PMID24454836
PMCPMC3893189
OpenAlexW2067413759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.